CARE Ratings Q2 FY27 Profit Rises 28% to ₹73 Crore

CARE Ratings Ltd reported a consolidated net profit of ₹72.37 crore for the quarter ended September 30, 2026, while a PTI report rounded the figure to ₹73 crore and said profit rose 28% year-on-year. Consolidated revenue for the quarter stood at ₹164.13 crore. The board also approved an interim dividend of ₹10 per share for FY27 and considered agreements to sell stakes in CareEdge Global IFSC Limited.

Board meeting concluded on October 29

The company had informed the exchanges on October 12 that its board would meet on October 29, 2026. The agenda included unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. It also included the consideration of an interim dividend, if any, for FY27. The results were declared on October 29.

Quarterly profit rose from the previous year

CARE Ratings reported a 28% increase in net profit for the September quarter. Net profit was ₹72.37 crore, or about ₹73 crore when rounded, compared with ₹57 crore reported for the corresponding quarter of the previous year according to the PTI report. The result indicates a higher profit base in the second quarter compared with a year earlier.

Consolidated revenue was ₹164.13 crore

Consolidated revenue in Q2 FY27 was ₹164.13 crore, converted from the reported ₹16,413.34 lakh. The PTI report separately put total income at ₹180 crore. Revenue and total income are different measures, and the available information does not provide a detailed break-up of the difference. Therefore, the two figures should not be treated as interchangeable.

Half-year revenue crossed ₹275 crore

For the first half of FY27, CARE Ratings reported consolidated revenue of ₹275.81 crore, converted from ₹27,581.29 lakh. The half-year figure covers the June and September quarters. It provides the broader operating-revenue context for the company’s first six months of the financial year.

Interim dividend approved at ₹10 per share

The board approved an interim dividend of ₹10 per equity share for FY27. This follows the company’s earlier FY26 dividend actions, when it paid an interim dividend of ₹8 per share and recommended a final dividend of ₹14 per share, subject to shareholder approval. The current announcement is an interim dividend for the ongoing financial year and is separate from past distributions.

Agreements involve CareEdge Global IFSC Limited

Alongside the financial results and dividend decision, agreements were approved to sell stakes in CareEdge Global IFSC Limited. The supplied information does not specify the size of the stakes, the transaction value, the buyer, or the closing timeline. These details will be important for assessing the financial and strategic effect of the proposed transactions once disclosed.

Key figures from the Q2 FY27 announcement

Why the distinction between revenue and income matters

The reported quarterly revenue of ₹164.13 crore is the consolidated revenue figure provided in the results data. The ₹180 crore figure cited by PTI is total income. Financial reporting can include items beyond operating revenue within total income, including other income, but the supplied material does not provide the detailed composition for Q2 FY27. Investors should therefore rely on the company’s complete results filing for line-item comparisons.

Context from earlier FY26 distributions

CARE Ratings had declared a ₹14-per-share dividend with an ex-dividend date of June 25, 2026. Its FY26 annual-report information also stated that the company paid an interim dividend of ₹8 per share and recommended a final dividend of ₹14 per share. The newly approved ₹10-per-share interim dividend adds a fresh shareholder-return decision in FY27.

Market relevance for investors

The Q2 result combines higher year-on-year profit, reported consolidated revenue growth in the half year, and an interim dividend approval. For investors, the immediate disclosed figures are the quarterly profit of ₹72.37 crore, quarterly revenue of ₹164.13 crore, and the ₹10 dividend per share. The proposed CareEdge Global IFSC stake-sale agreements are also relevant, although their financial impact cannot be quantified from the information available.

What to watch after the results

The next disclosures to watch are the detailed unaudited financial statements, dividend record-date and payment information, and terms of the CareEdge Global IFSC Limited stake transactions. These updates can clarify the composition of total income, the dividend timetable, and the status of the agreements. Until then, the October 29 announcement establishes the company’s Q2 FY27 profit, revenue, and interim dividend decisions.

Conclusion

CARE Ratings closed Q2 FY27 with consolidated net profit of ₹72.37 crore, consolidated revenue of ₹164.13 crore, and first-half revenue of ₹275.81 crore. The board’s approval of a ₹10-per-share interim dividend and agreements related to CareEdge Global IFSC Limited were the other key outcomes from the October 29 meeting.